ODYSSEY THERAPEUTICS
Live / Applied — First extension granted (statement of use) (as of 31 Mar 2026)
What this means for you
Not registered yet, but its 10 Jan 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98951736
- Mark type
- Design + words
- Filed
- 10 Jan 2025
- Published for opposition
- 19 Aug 2025
- Attorney of record
- Rebecca Dalton
Goods and services
- Class 005 — Pharmaceuticals: Molecules used as a component in pharmaceutical preparations for the treatment of auto-immune diseases; Pharmaceutical products and preparations for the treatment of auto-immune diseases
- Class 042 — Scientific and technological services: Development of molecules for use by others in developing and designing pharmaceutical products and preparations; Providing medical and scientific research information in the field of pharmaceuticals
Owner
- Odyssey Therapeutics, Inc., Boston, MA, US
- Odyssey Therapeutics, Inc., Boston, MA, US
Prosecution history
- 01 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Mar 2026 — SOU EXTENSION 1 GRANTED
- 31 Mar 2026 — SOU EXTENSION 1 FILED
- 31 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 14 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 Aug 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Aug 2025 — PUBLISHED FOR OPPOSITION
- 13 Aug 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Jul 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Jun 2025 — ASSIGNED TO EXAMINER
- 08 Jun 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 08 Jun 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 10 Jan 2025 — APPLICATION FILING RECEIPT MAILED
- 10 Jan 2025 — NEW APPLICATION ENTERED